Results 101 to 110 of about 104,468 (212)

Advantages of COVID-19 vaccine in the T cell immune response

Shanghai yufang yixue
ObjectiveTo illustrate the mechanism of COVID-19 vaccine in the T cell immune response.MethodsBased on the characteristics of T cell and B cell immune response， we matched the data of incubation periods across the SARS-CoV-2 prototype strain， Delta ...
ZHUO Jiatong
doaj   +1 more source

Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines

, 2008
[[abstract]]Current egg-based influenza vaccine production technology, which is labor intensive and slow, would not be able to meet demand during an influenza pandemic.
Hu, AYC;Weng, TC;Tseng, YF;Chen, YS;Wu, CH;Hsiao, S;Chou, AH;Chao, HJ;Gu, A;Wu, SC;Chong, P;Lee, MS
core   +1 more source

Haemophilus influenzae type b reemergence after combination immunization

, 2006
An increase in Haemophilus influenzae type b (Hib) in British children has been linked to the widespread use of a diphtheria/tetanus/acellular pertussis combination vaccine (DTaP-Hib).
Mary P.E. Slack, Heath, PT, Diane Irving, Slack, MPE, Nik G. Johnson, Lee, YC ; https://orcid.org/, Irving, D, Sheldon, J, Gail F. Balfour, Joanna Sheldon, Johnson, NG, Ruggeberg, JU, Balfour, GF, Slack, MP, Y. Chen Lee, Heath, PI, Pollard, AJ, Jens U. Ruggeberg, Paul T. Heath, Pollard, Andrew, Andrew J. Pollard, Lee, YC, Liddy, H, Helen Liddy   +23 more
core   +1 more source

Inactivated Vaccine [PDF]

, 2020
openaire   +1 more source

Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.

, 2016
BACKGROUND: Observational studies have suggested that girls have higher mortality if their most recent immunization is an inactivated vaccine rather than a live vaccine.
Michael D. Libman, Whittle, Hilton C, Benn, Christine S., Aaby, Peter, Henrik Ravn, Christine S. Benn, Peter Aaby, Hilton C. Whittle, Libman, Michael D., Rodrigues, Amabelia, Ravn, Henrik, Badara Samb, Benn, Christine S, Samb, Badara, Ibrahim, Salah A., Libman, Michael D, Ibrahim, Salah A, Amabelia Rodrigues, Salah A. Ibrahim   +18 more
core   +1 more source

Emulsified nanoparticles containing inactivated influenza virus and CpG oligodeoxynucleotides critically influences the host immune responses in mice.

, 2010
BackgroundAntigen sparing and cross-protective immunity are regarded as crucial in pandemic influenza vaccine development. Both targets can be achieved by adjuvantation strategy to elicit a robust and broadened immune response.
Ai-Hsiang Chou, Su-Chen Lin, Chih-Hsiang Leng, Chong Pele, Liu Shih-Jen, Liao Chien-Chun, Chia-Hsin Hsiao, Hu Alan Yung-Chih, Lin Su-Chen, Wu Huang-Pi, Shih-Jen Liu, Huang Chiung-Yi, Hung-Ren Yang, Leng Chih-Hsiang, Alan Yung-Chih Hu, Hsiao Chia-Hsin, Chao Hsin-Ju, Ming-Hsi Huang, Hsin-Wei Chen, Huang Ming-Hsi, Chien-Chun Liao, Chiung-Yi Huang, Hsin-Ju Chao, Chuang Po-Wei, Chen Hsin-Wei, Huang-Pi Wu, Pele Chong, Yang Hung-Ren, Po-Wei Chuang, Chou Ai-Hsiang, Huang, MH;Lin, SC;Hsiao, CH;Chao, HJ;Yang, HR;Liao, CC;Chuang, PW;Wu, HP;Huang, CY;Leng, CH;Liu, SJ;Chen, HW;Chou, AH;Hu, AYC;Chong, PL   +30 more
core   +1 more source

T-Cell Response Induced in Trivalent Inactivated Vaccine Recipients

, 2008
Among 17 HLA-A2-positive healthy adults, CD8+ T-cell responses against an HLA-A2-restricted matrix protein 1 (M1) epitope increased after immunization with trivalent inactivated influenza vaccine (TIV) in two individuals.
Masanori Terajima, John Cruz, Laura Orphin, Mary Dawn T. Co, Pazoles, Pamela P., Terajima, Masanori, Co, Mary Dawn T., Francis A. Ennis, Leporati, Anita M., Jameson, Julie Marie, Anita M. Leporati, Orphin, Laura, Babon, Jenny Aurielle B, Julie Jameson, Ennis, Francis A., Jenny Aurielle B. Babon, Pamela Pazoles, Cruz, John   +17 more
core   +1 more source

Production and Evaluation of an Inactivated Adjuvanted Vaccine against Canine Parvovirus in Morocco

The study conducted in Morocco focused on addressing the challenges posed by canine parvovirus (CPV-2) through comprehensive research, vaccine development, and efficacy assessment.
Hajar Moudhich, Chafiqa Loutfi, Said Mouhri, Mustapha Hammouchi, Ghizlane Sebbar, Safae El Azhari, Mourad Drifa, Farid Amraoui   +7 more
core   +1 more source

Enhanced Inactivated Poliovirus Vaccine [PDF]

Canadian Journal of Infectious Diseases and Medical Microbiology, 1994
openaire   +3 more sources

Cost-effectiveness of routine influenza vaccination program for individuals aged 65 years and older in Japan: Substituting standard-dose inactivated vaccine with high-dose inactivated vaccine. [PDF]

IJID Reg
Hoshi SL, Seposo X, Kondo M.
europepmc   +1 more source